Congestive heart failure in patients treated with doxorubicin

20032,246 citationsJournal Articlebronze Open Access

Authors

Sandra M. Swain · National Institutes of Health

Michael S. Ewer · The University of Texas MD Anderson Cancer Center

Abstract

Doxorubicin-related CHF occurs with greater frequency and at a lower cumulative dose than previously reported. These findings further indicate that LVEF is not an accurate predictor of CHF in patients who receive doxorubicin.

Topics & Keywords

Chemotherapy-induced cardiotoxicity and mitigation Cancer Treatment and Pharmacology Electron Spin Resonance Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 97, Issue 11, pp. 2869-2879

DOI: 10.1002/cncr.11407

Field-Weighted Citation Impact: 18.44